Daiwa Securities Group
SLXP

Daiwa Securities Group’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Daiwa Securities Group’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,400
Closed -$242K – 1026
2015
Q1 		$242K Buy
1,400
+200
+17% +$29.4K ﹤0.01% 607
2014
Q4 		$138K Buy
1,200
+410
+52% +$49.7K ﹤0.01% 737
2014
Q3 		$123K Buy
+790
New +$115K ﹤0.01% 767
2013
Q3 		– Sell
-400
Closed -$26K – 928
2013
Q2 		$26K Buy
+400
New +$22.9K ﹤0.01% 849

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Daiwa Securities Group's SLXP Position: Q2 2015 in Review

Daiwa Securities Group sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 1,400 shares — an estimated $242K sold.

Daiwa Securities Group first reported a position in SLXP in Q2 2013 and held it in 4 quarters. The position peaked at $242K in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Daiwa Securities Group reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Daiwa Securities Group sold 1,400 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $242K.
  • Daiwa Securities Group first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 4 quarters.
  • Daiwa Securities Group's SALIX PHARMACEUTICALS LTD DEL position peaked at $242K in Q1 2015.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Daiwa Securities Group's 13F filing for Q2 2015, filed 5 Aug 2015.